Selected article for: "caution interpret and high quality"

Author: Zhiheng Xu; Jianmeng Zhou; Yongbo Huang; Xuesong Liu; Yonghao Xu; Sibei Chen; Dongdong Liu; Zhimin Lin; Xiaoqing Liu; Yimin Li
Title: The efficacy of convalescent plasma for the treatment of severe influenza
  • Document date: 2020_2_23
  • ID: 4pe9o59g_45
    Snippet: Our analyses suggested that convalescent plasma may not have a clinically relevant impact in reducing the rate of mortality in patients with influenza. We also found non-significant reductions in days in ICU and hospital, and days on mechanical We included 5 high quality RCTs of convalescent plasma and H-IVIG use in severe influenza. The evidence for a reduction in mortality associated with convalescent plasma was strongest for influenza A (H1N1).....
    Document: Our analyses suggested that convalescent plasma may not have a clinically relevant impact in reducing the rate of mortality in patients with influenza. We also found non-significant reductions in days in ICU and hospital, and days on mechanical We included 5 high quality RCTs of convalescent plasma and H-IVIG use in severe influenza. The evidence for a reduction in mortality associated with convalescent plasma was strongest for influenza A (H1N1) (17) . But we should interpret this with an appropriate level of caution because of the limited sample size (n=17) and early use (onset within 5 days). In addition, the pooled data of 4 trails (n=567) that All rights reserved. No reuse allowed without permission. author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • convalescent plasma and limited sample size: 1
    • convalescent plasma and mechanical day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • convalescent plasma and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • convalescent plasma and non significant reduction: 1
    • limited sample size and mechanical day: 1
    • limited sample size and mortality rate: 1, 2, 3, 4, 5, 6
    • mechanical day and mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • mechanical day and patient mortality rate: 1
    • mortality rate and non significant reduction: 1, 2, 3
    • mortality rate and patient mortality rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • mortality rate and patient mortality rate reduce: 1, 2, 3